Acessibilidade / Reportar erro

Drug prophylaxis of deep venous thrombosis in patients submitted to trauma surgery in a university hospital

BACKGROUND: Annually, millions of people are victims of trauma around the world. Besides the social and economic consequences caused by it, many of these patients need surgical treatment, thus generating greater risk to life. Venous thromboembolism, a consequence of deep vein thrombosis, represents a major cause of the morbidity and mortality in postoperative state, and it could be avoided with adequate prophylaxis. OBJECTIVE: To evaluate the use of chemoprophylaxis for deep vein thrombosis, in patients undergoing emergency trauma surgery in a teaching hospital. METHODS: A cross-sectional analytic study was conducted with 153 patients admitted to Cajuru University Hospital, in Curitiba, Paraná, in a two-month period. Records of patients who required surgery due to trauma were prospectively analyzed. The study included those classified as high and medium risk for deep vein thrombosis. Then, it was identified whether or not the drug prophylaxis was used. A statistical analysis was descriptively performed. RESULTS: Of the 153 patients included, 99 (64.7%) were classified as high risk for deep vein thrombosis and 54 (35.3%) as medium risk. Of the total, 144 (94%) did not receive prophylaxis and nine (6%) did. On those who received prophylaxis, only four patients received the adequate. CONCLUSIONS: Prophylaxis of venous thrombosis disease is not performed routinely in patients of medium and high risk of developing deep vein thrombosis, who underwent trauma surgery. And, when performed, it is often inappropriate.

prophylaxis; trauma; venous thrombosis


Sociedade Brasileira de Angiologia e de Cirurgia Vascular (SBACV) Rua Estela, 515, bloco E, conj. 21, Vila Mariana, CEP04011-002 - São Paulo, SP, Tel.: (11) 5084.3482 / 5084.2853 - Porto Alegre - RS - Brazil
E-mail: secretaria@sbacv.org.br